Physician profile
Yining Lu
NPI 1346867843
$13,012.88
in general payments reported to CMS, 2019-2025
10 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $329 · 2022: $394 · 2023: $741 · 2024: $722 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $9,500 · Food and Beverage: $2,213 · Travel and Lodging: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $9,500.00 |
| Food and Beverage | $2,213.39 |
| Travel and Lodging | $576.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $9,500.00 | 2025 | |
| Stryker Corporation | $2,015.85 | 2021-2025 | Gamma, Blueprint Patient Specific Instrumentation, Axsos |
| Encore Medical, Lp | $530.96 | 2025 | Djo Surgical |
| Kyocera Medical Technologies, INC. | $358.49 | 2023 | |
| Depuy Synthes Sales INC. | $211.45 | 2024 | Tfn-Advance |
| Arthrex, INC. | $153.83 | 2023 | |
| Heron Therapeutics, INC. | $83.92 | 2025 | Zynrelef |
| Medtronic, INC. | $74.01 | 2023 | Unid_pass |
| Osteocentric Technologies, INC. | $50.79 | 2022 | |
| Lightbody Medical Technologies INC | $33.58 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yining Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.